Search research articles
Contact Us
Filters
Showing results (1-10 of 133) with videos related to
Page
of 14
Sort By:
Cancer Cell
|
December 10, 2024
Molecular subtyping in urothelial carcinoma treatment
Xiaowen Wu, Xinan Sheng
JAMA Oncology
|
April 9, 2026
Challenges in Interpreting MELATORCH Trial Outcomes-Reply
Juan Li, Xinan Sheng, Jun Guo
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
July 9, 2026
Breakthroughs in malignancy therapy: New advances and emerging trends in renal cell carcinoma
Xieqiao Yan, Xiaowen Wu, Xinan Sheng
International Urology and Nephrology
|
March 25, 2026
Stage-specific associations of HER2 overexpression with clinical and pathological features in bladder cancer: a systematic review and meta-analysis
Citing Guo, Jinchang Wei, Yajie Wang, et al.
BMC Cancer
|
February 26, 2011
Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases
Zhihong Chi, Siming Li, Xinan Sheng, et al.
BMC Cancer
|
June 3, 2014
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma
Siming Li, Yan Kong, Lu Si, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 2, 2019
Development of <sup>99m</sup>Tc-conjugated JS001 antibody for in vivo mapping of PD-1 distribution in murine
Xiaoyi Guo, Hua Zhu, Teli Liu, et al.
Future Oncology (London, England)
|
July 31, 2018
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data
Xinan Sheng, Feng Bi, Xiubao Ren, et al.
Cancer Biology & Medicine
|
September 23, 2025
Advances in antibody-drug conjugates for urothelial carcinoma treatment
Jinchang Wei, Bixia Tang, Xieqiao Yan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2011
A randomised phase II trial of 1 month versus 1 year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patients
Lili Mao, Lu Si, Zhihong Chi, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 133) with videos related to
Sort By:
Page
of 14
Cancer Cell
|
December 10, 2024
Molecular subtyping in urothelial carcinoma treatment
Xiaowen Wu, Xinan Sheng
JAMA Oncology
|
April 9, 2026
Challenges in Interpreting MELATORCH Trial Outcomes-Reply
Juan Li, Xinan Sheng, Jun Guo
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
July 9, 2026
Breakthroughs in malignancy therapy: New advances and emerging trends in renal cell carcinoma
Xieqiao Yan, Xiaowen Wu, Xinan Sheng
International Urology and Nephrology
|
March 25, 2026
Stage-specific associations of HER2 overexpression with clinical and pathological features in bladder cancer: a systematic review and meta-analysis
Citing Guo, Jinchang Wei, Yajie Wang, et al.
BMC Cancer
|
February 26, 2011
Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases
Zhihong Chi, Siming Li, Xinan Sheng, et al.
BMC Cancer
|
June 3, 2014
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma
Siming Li, Yan Kong, Lu Si, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 2, 2019
Development of <sup>99m</sup>Tc-conjugated JS001 antibody for in vivo mapping of PD-1 distribution in murine
Xiaoyi Guo, Hua Zhu, Teli Liu, et al.
Future Oncology (London, England)
|
July 31, 2018
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data
Xinan Sheng, Feng Bi, Xiubao Ren, et al.
Cancer Biology & Medicine
|
September 23, 2025
Advances in antibody-drug conjugates for urothelial carcinoma treatment
Jinchang Wei, Bixia Tang, Xieqiao Yan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2011
A randomised phase II trial of 1 month versus 1 year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patients
Lili Mao, Lu Si, Zhihong Chi, et al.
Page
of 14